Anti-complement factor C1Q antibodies and uses thereof
US10927167B2 · kind B2 · utility
2Cited by
14References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2020 |
| Grant date | Feb 23, 2021 |
| Priority date | — |
| Expiry date | Feb 6, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4716
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides anti-C1q antibodies and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.